Can Computed Tomography Angiography (CTA) show a dot sign?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Computed Tomography Angiography (CTA) can show a dot sign, which is often referred to as the "spot sign" in the context of intracerebral hemorrhage, as noted in the 2024 study published in the Journal of the American College of Radiology 1.

Clinical Context and Significance

The presence or absence of a dot sign, or spot sign, on CTA can be useful in prognosis, especially in cases of intracerebral hemorrhage, as it may indicate active bleeding or the potential for hematoma expansion 1. This information is crucial for determining patient disposition and guiding further management.

Diagnostic Capabilities of CTA

CTA has a high sensitivity and specificity for identifying vascular lesions such as aneurysms or arteriovenous malformations, with values exceeding 90% compared to catheter arteriography 1. This makes CTA a valuable tool in the follow-up evaluation of the underlying etiology of intraparenchymal hemorrhage (IPH).

Interpretation of Dot Sign

When a dot sign is identified on CTA, radiologists consider several factors, including its location, density, and relationship to surrounding structures, as well as the patient's clinical presentation, to determine its significance. The excellent spatial resolution of CTA and the use of contrast material that highlights vascular structures enable the visualization of small dot-like structures, which could represent various findings such as small calcifications, tiny aneurysms, or contrast enhancement in small vessels.

Clinical Implications

The ability of CTA to show a dot sign has important clinical implications, particularly in the prognosis and management of patients with intracerebral hemorrhage. It is essential for healthcare providers to discuss the finding with patients to understand its clinical relevance in their specific situation. The 2024 study 1 emphasizes the utility of CTA in evaluating the underlying etiology of IPH and in guiding recommendations for imaging in suspected aneurysm, arteriovenous shunt lesion, or vasculitis.

From the Research

Computed Tomography Angiography (CTA) and the Dot Sign

  • The dot sign is a radiological finding that can be indicative of certain vascular conditions, but the provided studies do not directly address whether CTA can show a dot sign 2, 3, 4, 5, 6.
  • CTA is a non-invasive imaging technique used to visualize the vascular system, and it has been shown to be effective in diagnosing various vascular conditions, including intracranial aneurysms 2, 3, 6.
  • The accuracy of CTA in diagnosing intracranial aneurysms has been reported to be high, but it may be lower than previously thought, especially for small aneurysms (<5 mm) and those in certain locations 3, 6.
  • CTA has been compared to digital subtraction angiography (DSA) in several studies, and while CTA has been shown to be a useful diagnostic tool, it may not be as sensitive as DSA in certain situations 2, 3, 6.

Limitations of CTA

  • CTA may have limitations in detecting small aneurysms or those in certain locations, such as adjacent to bony structures or arising from small caliber parent vessels 3, 6.
  • The sensitivity of CTA may be lower than previously reported, especially in the setting of subarachnoid hemorrhage (SAH) 6.
  • CTA should be used with caution when used alone in the diagnosis of ruptured intracranial aneurysms, and it may be necessary to use additional imaging modalities, such as DSA, to confirm the diagnosis 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.